248 related articles for article (PubMed ID: 38486989)
1. The role of
Lin Y; Lubman DM
Acta Pharm Sin B; 2024 Mar; 14(3):1098-1110. PubMed ID: 38486989
[TBL] [Abstract][Full Text] [Related]
2. [Large-scale enrichment and identification of human urinary
Shang S; Dong H; Li Y; Zhang W; Li H; Qin W; Qian X
Se Pu; 2021 Jul; 39(7):686-694. PubMed ID: 34227365
[TBL] [Abstract][Full Text] [Related]
3. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
Guo Y; Jia W; Yang J; Zhan X
Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
[TBL] [Abstract][Full Text] [Related]
4. In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
Chen Z; Yu Q; Yu Q; Johnson J; Shipman R; Zhong X; Huang J; Asthana S; Carlsson C; Okonkwo O; Li L
Mol Cell Proteomics; 2021; 20():100081. PubMed ID: 33862227
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
6. Site-specific characterization and quantitation of N-glycopeptides in PKM2 knockout breast cancer cells using DiLeu isobaric tags enabled by electron-transfer/higher-energy collision dissociation (EThcD).
Chen Z; Yu Q; Hao L; Liu F; Johnson J; Tian Z; Kao WJ; Xu W; Li L
Analyst; 2018 May; 143(11):2508-2519. PubMed ID: 29687791
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
Xiao H; Suttapitugsakul S; Sun F; Wu R
Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
[TBL] [Abstract][Full Text] [Related]
8. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
[TBL] [Abstract][Full Text] [Related]
9. The Role of Glycosylation in Melanoma Progression.
De Vellis C; Pietrobono S; Stecca B
Cells; 2021 Aug; 10(8):. PubMed ID: 34440905
[TBL] [Abstract][Full Text] [Related]
10. Site-specific characterization of N-linked glycosylation in human urinary glycoproteins and endogenous glycopeptides.
Kawahara R; Saad J; Angeli CB; Palmisano G
Glycoconj J; 2016 Dec; 33(6):937-951. PubMed ID: 27234710
[TBL] [Abstract][Full Text] [Related]
11. Glycosylated proteins with abnormal glycosylation changes are potential biomarkers for early diagnosis of breast cancer.
Chang X; Obianwuna UE; Wang J; Zhang H; Qi G; Qiu K; Wu S
Int J Biol Macromol; 2023 May; 236():123855. PubMed ID: 36868337
[TBL] [Abstract][Full Text] [Related]
12. Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers.
Gao Z; Xu M; Yue S; Shan H; Xia J; Jiang J; Yang S
Curr Res Pharmacol Drug Discov; 2022; 3():100079. PubMed ID: 35005612
[TBL] [Abstract][Full Text] [Related]
13. Cell surface protein glycosylation in cancer.
Christiansen MN; Chik J; Lee L; Anugraham M; Abrahams JL; Packer NH
Proteomics; 2014 Mar; 14(4-5):525-46. PubMed ID: 24339177
[TBL] [Abstract][Full Text] [Related]
14. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
[TBL] [Abstract][Full Text] [Related]
15. Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation.
Shah P; Wang X; Yang W; Toghi Eshghi S; Sun S; Hoti N; Chen L; Yang S; Pasay J; Rubin A; Zhang H
Mol Cell Proteomics; 2015 Oct; 14(10):2753-63. PubMed ID: 26256267
[TBL] [Abstract][Full Text] [Related]
16. The role of glycans in the development and progression of prostate cancer.
Munkley J; Mills IG; Elliott DJ
Nat Rev Urol; 2016 Jun; 13(6):324-33. PubMed ID: 27091662
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in mass spectrometry-based glycoproteomics.
Frost DC; Li L
Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
[TBL] [Abstract][Full Text] [Related]
18. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
19. In-Depth Site-Specific O-Glycosylation Analysis of Glycoproteins and Endogenous Peptides in Cerebrospinal Fluid (CSF) from Healthy Individuals, Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD) Patients.
Chen Z; Wang D; Yu Q; Johnson J; Shipman R; Zhong X; Huang J; Yu Q; Zetterberg H; Asthana S; Carlsson C; Okonkwo O; Li L
ACS Chem Biol; 2022 Nov; 17(11):3059-3068. PubMed ID: 34964596
[TBL] [Abstract][Full Text] [Related]
20. Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells.
Xue B; Xiao K; Wang Y; Tian Z
J Proteomics; 2020 Feb; 212():103594. PubMed ID: 31759178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
